NASDAQ:ACHV - Achieve Life Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.84 -0.04 (-1.39 %)
(As of 09/26/2018 02:58 AM ET)
Previous Close$2.88
Today's Range$2.80 - $3.03
52-Week Range$2.40 - $38.45
Volume81,500 shs
Average Volume353,935 shs
Market Capitalization$11.33 million
P/E Ratio-0.13
Dividend YieldN/A
Beta1.93
Achieve Life Sciences logoAchieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is headquartered in Bothell, Washington.

Receive ACHV News and Ratings via Email

Sign-up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Diagnostic substances
Sub-IndustryBiotechnology
SectorMedical
SymbolNASDAQ:ACHV
CUSIP68230A10
Phone604-736-3678

Debt

Debt-to-Equity RatioN/A
Current Ratio5.64
Quick Ratio5.64

Price-To-Earnings

Trailing P/E Ratio-0.13
Forward P/E Ratio-0.43
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.06 million
Price / Sales2.55
Cash FlowN/A
Price / CashN/A
Book Value$6.59 per share
Price / Book0.43

Profitability

EPS (Most Recent Fiscal Year)($22.10)
Net Income$-10,580,000.00
Net MarginsN/A
Return on Equity-155.83%
Return on Assets-126.69%

Miscellaneous

Employees13
Outstanding Shares4,550,000
Market Cap$11.33 million

Achieve Life Sciences (NASDAQ:ACHV) Frequently Asked Questions

What is Achieve Life Sciences' stock symbol?

Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV."

When did Achieve Life Sciences' stock split? How did Achieve Life Sciences' stock split work?

Achieve Life Sciences's stock reverse split on Thursday, May 24th 2018. The 1-10 reverse split was announced on Wednesday, May 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 23rd 2018. An investor that had 100 shares of Achieve Life Sciences stock prior to the reverse split would have 10 shares after the split.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences Inc (NASDAQ:ACHV) issued its quarterly earnings results on Wednesday, August, 8th. The biopharmaceutical company reported ($1.82) EPS for the quarter. View Achieve Life Sciences' Earnings History.

When is Achieve Life Sciences' next earnings date?

Achieve Life Sciences is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Achieve Life Sciences.

What price target have analysts set for ACHV?

1 equities research analysts have issued twelve-month price objectives for Achieve Life Sciences' stock. Their forecasts range from $12.00 to $12.00. On average, they expect Achieve Life Sciences' share price to reach $12.00 in the next year. This suggests a possible upside of 322.5% from the stock's current price. View Analyst Price Targets for Achieve Life Sciences.

What is the consensus analysts' recommendation for Achieve Life Sciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Achieve Life Sciences.

Who are some of Achieve Life Sciences' key competitors?

Who are Achieve Life Sciences' key executives?

Achieve Life Sciences' management team includes the folowing people:
  • Dr. Richard A. B. Stewart, Chairman & CEO (Age 59)
  • Dr. Anthony Clarke, Pres, Chief Scientific Officer & Director (Age 62)
  • Mr. John A. Bencich, Exec. VP, CFO & COO (Age 41)
  • Dr. Cindy Jacobs, Exec. VP & Chief Medical Officer (Age 60)

Who are Achieve Life Sciences' major shareholders?

Achieve Life Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.98%). View Institutional Ownership Trends for Achieve Life Sciences.

Which institutional investors are selling Achieve Life Sciences stock?

ACHV stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Achieve Life Sciences.

How do I buy shares of Achieve Life Sciences?

Shares of ACHV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Achieve Life Sciences' stock price today?

One share of ACHV stock can currently be purchased for approximately $2.84.

How big of a company is Achieve Life Sciences?

Achieve Life Sciences has a market capitalization of $11.33 million and generates $5.06 million in revenue each year. The biopharmaceutical company earns $-10,580,000.00 in net income (profit) each year or ($22.10) on an earnings per share basis. Achieve Life Sciences employs 13 workers across the globe.

What is Achieve Life Sciences' official website?

The official website for Achieve Life Sciences is achievelifesciences.com.

How can I contact Achieve Life Sciences?

Achieve Life Sciences' mailing address is 1001 W. BROADWAY SUITE 400, VANCOUVER BC, V6H 4B1. The biopharmaceutical company can be reached via phone at 604-736-3678 or via email at [email protected]


MarketBeat Community Rating for Achieve Life Sciences (NASDAQ ACHV)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about Achieve Life Sciences and other stocks. Vote "Outperform" if you believe ACHV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/26/2018 by MarketBeat.com Staff

Featured Article: Technical Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel